Entasis Therapeutics Holdings Inc. Aktie
Aktien
A2N4R0
US2936141033
ETTX
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01.05.15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.05.15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04.11.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01.04.18 |
Director/Board Member | 58 | 01.08.17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01.08.17 |
% 1. Jan. | Kap. | |
---|---|---|
-2,31 % | 103 Mrd. | |
+0,56 % | 95,28 Mrd. | |
+1,69 % | 22,15 Mrd. | |
-17,37 % | 21,02 Mrd. | |
-9,30 % | 18,15 Mrd. | |
-41,01 % | 16,73 Mrd. | |
-14,85 % | 16,05 Mrd. | |
+3,21 % | 13,68 Mrd. | |
+33,54 % | 12,17 Mrd. |